TrialAnnals of the rheumatic diseases2009

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT).

P J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.